Ln Laboratories Profile
Key Indicators
- Authorised Capital ₹ 8.15 Cr
as on 04-01-2025
- Paid Up Capital ₹ 8.15 Cr
as on 04-01-2025
- Company Age 4 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
About Ln Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 8.15 Cr and a paid-up capital of Rs 8.15 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vakkalanka Raman, Gunneswara Prasad, Shamanvi Vakkalanka, and One other member serve as directors at the Company.
- CIN/LLPIN
U24239TG2020PTC139193
- Company No.
139193
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Feb 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ln Laboratories?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chonika Vakkalanka  | Director | 01-Feb-2021 | Current |
| Vakkalanka Raman | Director | 06-Mar-2021 | Current |
| Gunneswara Prasad | Director | 13-Feb-2020 | Current |
| Shamanvi Vakkalanka | Director | 13-Feb-2020 | Current |
Financial Performance of Ln Laboratories.
Ln Laboratories Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Ln Laboratories?
In 2021, Ln Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Asman Software Solutions Private LimitedActive 13 years 4 monthsVakkalanka Raman is a mutual person
Ram Navami Green Film Technologies Private LimitedActive 1 year 5 monthsVakkalanka Raman, Gunneswara Prasad and 2 more are mutual person
- Rn Green Film Technologies Private LimitedActive 1 year 4 months
Vakkalanka Raman, Gunneswara Prasad and 2 more are mutual person
- Ln Pharmaceuticals Private LimitedActive 4 years 10 months
Vakkalanka Raman, Gunneswara Prasad and 2 more are mutual person
- R9 Projects And Developers Private LimitedActive 1 year 8 months
Vakkalanka Raman is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ln Laboratories?
Ln Laboratories has a workforce of 37 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ln Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ln Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
